Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Spine Osteoarthritis Pain Medicine Market Size Growth Rate by Type
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Market Segment by Application
1.4.1 Global Spine Osteoarthritis Pain Medicine Market Share by Application (2018-2025)
1.4.2 Medical Care
1.4.3 Personal Care
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spine Osteoarthritis Pain Medicine Market Size
2.1.1 Global Spine Osteoarthritis Pain Medicine Revenue 2013-2025
2.1.2 Global Spine Osteoarthritis Pain Medicine Sales 2013-2025
2.2 Spine Osteoarthritis Pain Medicine Growth Rate by Regions
2.2.1 Global Spine Osteoarthritis Pain Medicine Sales by Regions 2013-2018
2.2.2 Global Spine Osteoarthritis Pain Medicine Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Spine Osteoarthritis Pain Medicine Sales by Manufacturers
3.1.1 Spine Osteoarthritis Pain Medicine Sales by Manufacturers 2013-2018
3.1.2 Spine Osteoarthritis Pain Medicine Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Spine Osteoarthritis Pain Medicine Revenue by Manufacturers (2013-2018)
3.2.2 Spine Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Spine Osteoarthritis Pain Medicine Market Concentration Ratio (CR5 and HHI)
3.3 Spine Osteoarthritis Pain Medicine Price by Manufacturers
3.4 Key Manufacturers Spine Osteoarthritis Pain Medicine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Spine Osteoarthritis Pain Medicine Market
3.6 Key Manufacturers Spine Osteoarthritis Pain Medicine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2013-2018)
4.1.2 Injection Sales and Revenue (2013-2018)
4.1.3 External Sales and Revenue (2013-2018)
4.2 Global Spine Osteoarthritis Pain Medicine Sales Market Share by Type
4.3 Global Spine Osteoarthritis Pain Medicine Revenue Market Share by Type
4.4 Spine Osteoarthritis Pain Medicine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Spine Osteoarthritis Pain Medicine Sales by Application
6 North America
6.1 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Company
6.2 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Type
6.3 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Application
6.4 North America Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
6.4.1 North America Spine Osteoarthritis Pain Medicine Sales by Countries
6.4.2 North America Spine Osteoarthritis Pain Medicine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Company
7.2 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Type
7.3 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Application
7.4 Europe Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
7.4.1 Europe Spine Osteoarthritis Pain Medicine Sales by Countries
7.4.2 Europe Spine Osteoarthritis Pain Medicine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Company
8.2 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Type
8.3 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Application
8.4 Asia Pacific Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
8.4.1 Asia Pacific Spine Osteoarthritis Pain Medicine Sales by Countries
8.4.2 Asia Pacific Spine Osteoarthritis Pain Medicine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Company
9.2 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Type
9.3 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Application
9.4 Central & South America Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
9.4.1 Central & South America Spine Osteoarthritis Pain Medicine Sales by Countries
9.4.2 Central & South America Spine Osteoarthritis Pain Medicine Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Type
10.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Application
10.3 Middle East and Africa Spine Osteoarthritis Pain Medicine Breakdown Data by Countries
10.3.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Countries
10.3.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.1.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.2.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.3.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.4.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.5.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.6.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.7.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.8.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.9.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Spine Osteoarthritis Pain Medicine
11.10.4 Spine Osteoarthritis Pain Medicine Product Introduction
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.12 TEVA
11.13 Almatica Pharma
11.14 Astellas Pharma
11.15 Tide Pharmaceutical
11.16 Iroko Pharmaceuticals
11.17 Hengrui Pharmaceutical
11.18 Abiogen Pharma
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Spine Osteoarthritis Pain Medicine Sales Channels
12.2.2 Spine Osteoarthritis Pain Medicine Distributors
12.3 Spine Osteoarthritis Pain Medicine Customers
13 Market Forecast
13.1 Global Spine Osteoarthritis Pain Medicine Sales and Revenue Forecast 2018-2025
13.2 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Type
13.3 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Application
13.4 Spine Osteoarthritis Pain Medicine Forecast by Regions
13.4.1 Global Spine Osteoarthritis Pain Medicine Sales Forecast by Regions 2018-2025
13.4.2 Global Spine Osteoarthritis Pain Medicine Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Spine Osteoarthritis Pain Medicine Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Spine Osteoarthritis Pain Medicine Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma
【免責事項】
https://www.globalresearch.jp/disclaimer